Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Susquehanna Growth Equity is an active growth equity investment firm founded in 2006 and backed by entrepreneurs associated with Susquehanna. The firm invests primarily in software, data, information services, and tech-enabled businesses rather than developing therapeutics or medical products itself. While it has made investments in healthcare and life sciences technology companies such as MediSpend and other healthcare IT assets, it is not a biotech, pharma, or healthcare operating company. The business is best understood as a private growth investor with exposure to healthcare technology alongside broader enterprise software and fintech sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Susquehanna Growth Equity.